Royce & Associates’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-18,200
Closed -$9.67M 1441
2013
Q3
$9.67M Sell
18,200
-8,467
-32% -$4.5M 0.03% 674
2013
Q2
$6.24M Buy
+26,667
New +$6.24M 0.02% 778